Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Research Suggests A Better Approach to Breast Cancer Screening

By HospiMedica International staff writers
Posted on 14 Jun 2016
Researchers are unhappy with current models for determining mammography screening risk/benefit ratios, and suggest that the measurement of Quality-Adjusted Life-Years (QALYs) gained, when breast cancer is prevented, could be more accurate.

Researchers in Norway found that there were large uncertainties in the evaluation a long running breast cancer screening program in the country, especially in the estimates of over-diagnoses.

The researchers from the Department of Screening at the Cancer Registry of Norway (Oslo, Norway) studied the benefit/detriment ratio estimates of the Norwegian Breast Cancer Screening Program (NBCSP) in 2015, and presented the results at the annual meeting of the Radiological Society of North America (RSNA 2015). More...
The results were published in the March 2016, issue of the Journal of Medical Screening. Under the program, all women aged 50 to 69 receive an invitation for screening every two years. The Research Council of Norway also evaluated the screening program between 2007 and 2015.

According to the researchers, the range of estimates varies widely and needs to be interpreted carefully before publication. In addition the estimates include two different variables that are not comparable — lives saved and cases of over-diagnosis. The researchers found that the program saved about one life per 1-2 women with epidemiologic over-diagnosis. The researchers suggest that using a simple risk/benefit ratio could be misleading. Instead, they propose the use of Quality-Adjusted Life-Years (QALYs) gained when breast cancer is prevented, compared to QALYs lost in cases of over diagnosis.

Norway’s health minister decided to continue the NBCSP program without changes despite the findings of the researchers.

Solveig Hofvind, PhD, researcher, Department of Screening, Cancer Registry of Norway, said, “Our research demonstrates that it’s very difficult to find clear numbers to show the risk/benefit ratio of mammography screening. The range is so wide and it depends on so many different factors, that it’s important to understand the screening logistics and the epidemiology in order to choose the right model to estimate such a ratio. In any event, if a patient asks for information about risk/benefit ratios, that information should be shared and interpreted with substantial. I know women may ask about this ratio and we have to be prepared to give them information with the best knowledge we have today.”

Related Links:
Cancer Registry of Norway


Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Digital Radiography System (Ceiling Free)
Digix CF Series
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.